One-liner#
Risk-stratify syncope to identify cardiac causes (arrhythmia, structural) requiring urgent evaluation, then efficiently manage the common benign causes (vasovagal, orthostatic) without over-testing low-risk patients. (Per 2017 ACC/AHA/HRS Syncope Guidelines and 2018 ESC Syncope Guidelines)
Quick nav#
- Red flags / send to ED
- Key history
- Focused exam
- Differential (quick pattern recognition)
- Workup
- Initial management
- Management by diagnosis
- Follow-up
- Patient instructions
- Smartphrase snippets
Red flags / send to ED#
- Syncope during exertion (not after)
- Syncope while supine or seated
- Syncope preceded by palpitations or chest pain
- Family history of sudden cardiac death <50 years
- Known structural heart disease (HCM, severe AS, arrhythmogenic cardiomyopathy, prior MI with reduced EF)
- Abnormal ECG: long QT, short QT, Brugada pattern, WPW, bifascicular block, Q waves suggesting prior MI
- New neurologic deficits (stroke mimic)
- Significant injury from fall (head trauma, fracture)
- Recurrent syncope without clear trigger
- Syncope in patient with pacemaker/ICD (device malfunction)
Key history#
Characterize the event:
- True syncope (complete LOC with spontaneous recovery) vs presyncope (near-faint) vs other (seizure, vertigo, hypoglycemia)
- Duration of LOC (seconds = typical syncope; prolonged = seizure or cardiac arrest with resuscitation)
- Prodrome: lightheadedness, warmth, nausea, tunnel vision, diaphoresis (vasovagal) vs none (cardiac)
- Position: standing (orthostatic, vasovagal) vs sitting/supine (cardiac more likely)
- Activity: exertional (cardiac) vs post-exertional (vasovagal) vs at rest
Triggers and context:
- Prolonged standing, hot environment, dehydration, pain, blood draw, emotional stress (vasovagal)
- Positional change: lying to standing (orthostatic)
- Micturition, defecation, coughing, swallowing (situational)
- Head turning, shaving, tight collar (carotid sinus hypersensitivity—elderly)
- Medications: antihypertensives, diuretics, vasodilators, QT-prolonging drugs
Witness account (critical):
- Movements during LOC: brief myoclonic jerks (common in syncope) vs sustained tonic-clonic activity (seizure)
- Color: pallor (syncope) vs cyanosis (seizure, cardiac arrest)
- Duration of confusion after: immediate recovery (syncope) vs prolonged postictal state (seizure)
- Pulse during event if checked
Risk factors for cardiac syncope:
- Age >60
- Known heart disease: CAD, HF, valvular disease, cardiomyopathy
- Family history: sudden death <50, HCM, long QT, Brugada, ARVC
- Palpitations preceding syncope
- Exertional syncope
- Syncope while supine
Focused exam#
- Vitals: orthostatic BP and HR (lying → standing at 1 and 3 minutes; positive if SBP drop ≥20 or DBP drop ≥10 with symptoms)
- Cardiac: murmurs (AS, HCM), irregular rhythm, S3 (HF), JVD
- Carotid: bruits (avoid carotid massage if bruit present)
- Neuro: focal deficits (stroke), tongue laceration (seizure), postictal confusion
- Skin: pallor, diaphoresis, injuries from fall
- Rectal: if GI bleed suspected (melena, anemia)
Differential (quick pattern recognition)#
Common/likely (outpatient)#
| Diagnosis | Keywords patients use | Key clues | Focused exam clues | Initial next step |
|---|---|---|---|---|
| Vasovagal syncope | “Felt hot,” “nauseated,” “vision went dark” | Prodrome; trigger (standing, pain, blood); rapid recovery | Normal exam; may reproduce with prolonged standing | Reassurance; trigger avoidance; hydration |
| Orthostatic hypotension | “Got up too fast,” “dizzy when standing” | Positional; meds (diuretics, antihypertensives); dehydration; elderly | Positive orthostatic vitals | Review meds; hydration; compression stockings |
| Situational syncope | “Passed out while urinating/coughing” | Clear situational trigger | Normal exam | Avoid trigger; sit during trigger activity |
| Medication-induced | “Started new BP med” | Temporal relationship to new/increased medication | Orthostatic hypotension | Adjust medication |
| Vasovagal (carotid sinus) | “Turned my head,” “tight collar” | Elderly; head turning trigger | Carotid hypersensitivity (test with caution) | Avoid triggers; cardiology if recurrent |
Can’t-miss / urgent#
| Diagnosis | Keywords patients use | Key clues | Focused exam clues | Initial next step |
|---|---|---|---|---|
| Arrhythmia (VT, bradycardia, SVT) | “Heart racing then passed out,” no warning | Palpitations before; known heart disease; abnormal ECG | May be normal between events | ECG; monitor; cardiology referral |
| Aortic stenosis | “Passed out with exertion” | Exertional; elderly; known murmur | Harsh systolic murmur, diminished A2 | Echo; urgent cardiology |
| Hypertrophic cardiomyopathy | “Passed out playing sports” | Young; exertional; family hx sudden death | Systolic murmur that increases with Valsalva | Echo; urgent cardiology; activity restriction |
| Pulmonary embolism | “Sudden,” “short of breath” | VTE risk factors; dyspnea; pleuritic pain | Tachycardia, hypoxia | ED if suspected |
| Aortic dissection | “Tearing pain,” “worst pain” | Sudden severe pain; HTN; pulse deficit | BP differential; new AR murmur | ED now |
| Seizure | “Bit tongue,” “confused after,” “shaking” | Prolonged LOC; witnessed tonic-clonic; postictal | Tongue laceration; postictal confusion | Neuro workup |
| Hypoglycemia | “Diabetic,” “missed meal” | Diabetes on insulin/sulfonylurea; missed meal | Diaphoresis; confusion; responds to glucose | Check glucose; adjust diabetes regimen |
Workup#
All patients:
- ECG: look for arrhythmia, long/short QT, Brugada, WPW, heart block, prior MI (Q waves), LVH
- Orthostatic vitals (lying → standing)
- Basic labs: CBC (anemia), BMP (electrolytes, glucose), consider troponin if cardiac concern
Risk stratification tools:
Canadian Syncope Risk Score (CSRS) — validated for 30-day serious adverse events:
- Predisposition to vasovagal: −1 point
- Heart disease history or elevated BNP: +1 point
- SBP <90 or >180 mmHg: +2 points
- Elevated troponin: +2 points
- Abnormal QRS axis: +1 point
- QRS >130 ms: +1 point
- QTc >480 ms: +2 points
- ED diagnosis of cardiac syncope: +2 points
- ED diagnosis of vasovagal syncope: −2 points
| Score | 30-day risk | Disposition |
|---|---|---|
| −3 to −1 | 0.4–1.2% | Safe for outpatient |
| 0–1 | 1.9–3.1% | Consider outpatient with close follow-up |
| 2–3 | 5.5–8.6% | Consider observation/admission |
| ≥4 | 12–25% | Admission recommended |
San Francisco Syncope Rule — older, less validated; CSRS preferred per 2017 ACC/AHA/HRS guidelines.
High-risk features (consider ED/admission):
- Abnormal ECG
- History of CHF or structural heart disease
- Hematocrit <30%
- Systolic BP <90
- Shortness of breath
- Age >60 with no clear vasovagal trigger
Low-risk features (outpatient workup appropriate):
- Classic vasovagal prodrome and trigger
- Young, healthy, normal ECG
- Orthostatic hypotension with clear medication cause
- Situational syncope with identifiable trigger
Extended workup by clinical scenario:
| Scenario | Workup |
|---|---|
| Low risk, classic vasovagal | No further workup; reassurance |
| Suspected orthostatic | Review meds; volume status; consider autonomic testing if refractory |
| Suspected cardiac (abnormal ECG, structural heart disease, exertional) | Echo ($300–800); Holter or event monitor ($100–300); cardiology referral |
| Recurrent unexplained | Extended monitoring (30-day event monitor, implantable loop recorder); tilt table ($500–1500) if vasovagal suspected but atypical |
When to consider implantable loop recorder (ILR):
Per 2017 ACC/AHA/HRS guidelines, ILR is indicated (Class I) for:
- Recurrent unexplained syncope after initial evaluation (ECG, orthostatics, echo if indicated) is non-diagnostic
- Infrequent episodes (<monthly) unlikely to be captured by external monitors
- High-risk features but no diagnosis after initial workup
- Syncope causing significant injury requiring definitive diagnosis
ILR practical considerations:
- Device cost: $5,000–10,000 (often covered by insurance with appropriate documentation)
- Battery life: 3+ years of continuous monitoring
- Implantation: minor outpatient procedure by cardiology/EP
- Yield: diagnoses arrhythmia in 35–45% of unexplained syncope cases
- Refer to cardiology/EP for implantation decision
Carotid sinus massage (CSM):
Indicated for: unexplained syncope in patients >40 years, especially with head-turning triggers
Technique (perform with continuous ECG and BP monitoring):
- Patient supine with IV access available
- Massage one carotid at a time for 5–10 seconds
- Positive if reproduces symptoms with asystole >3 seconds or SBP drop >50 mmHg
Contraindications to CSM:
- Carotid bruit
- History of stroke/TIA within 3 months
- Known carotid stenosis >50%
- History of VT/VF
- Recent MI
| Suspected seizure | EEG; MRI brain; neurology referral | | Suspected PE | Wells score; D-dimer or CT-PA |
When NOT to do extensive workup:
- Single episode with classic vasovagal features, clear trigger, normal ECG, young healthy patient
- Clear orthostatic hypotension from identifiable medication
Initial management#
- Address immediate safety: driving restrictions until diagnosis clarified and treated
- Treat reversible causes: stop/reduce offending medications; rehydrate
- Risk stratify: low-risk patients can be managed outpatient; high-risk need ED/cardiology
- Document: detailed history including witness account, ECG findings, orthostatic vitals
Management by diagnosis#
Vasovagal syncope#
Education:
- Most common cause of syncope; not dangerous but can cause injury from falls
- Recognize prodrome (lightheadedness, warmth, nausea) and respond immediately
- Counterpressure maneuvers can abort episodes
Treatment:
Non-pharmacologic (first-line):
- Recognize and avoid triggers when possible
- At prodrome: lie down immediately, or if unable, cross legs and squeeze, squat, or grip hands tightly (counterpressure)
- Increase fluid intake (2–3 L/day) and salt intake (if no HTN/HF)
- Avoid prolonged standing; shift weight frequently
- Compression stockings (waist-high more effective than knee-high)
Pharmacologic (if refractory and frequent):
| Drug | Dose | Contraindications | Monitoring | Cost | Notes |
|---|---|---|---|---|---|
| Midodrine | 2.5–10 mg TID | Supine HTN; urinary retention; severe CAD | Supine BP | $$ | Alpha-agonist; avoid within 4h of bedtime; NNT ~4 for symptom reduction |
| Fludrocortisone | 0.1–0.2 mg daily | HF; HTN; hypokalemia | K, BP, edema, weight | $ | Volume expansion; monitor for hypokalemia; limited RCT evidence |
| Beta-blockers | Variable | Bradycardia; asthma | HR, BP | $ | POST trial showed no benefit; may help subset with high catecholamine state |
Per 2017 ACC/AHA/HRS guidelines, pharmacotherapy has limited evidence (Class IIb) and should be reserved for patients with frequent, recurrent vasovagal syncope despite non-pharmacologic measures.
Follow-up: 4–6 weeks if starting treatment; PRN if infrequent with good prodrome recognition. Driving restrictions per state law (typically no driving until symptom-free for specified period).
Orthostatic hypotension#
Education:
- Blood pressure drops when standing, causing lightheadedness or fainting
- Often medication-related or from dehydration
- Gradual position changes and countermeasures help
Treatment:
Non-pharmacologic (first-line):
- Rise slowly: sit at bedside before standing; wait 1–2 minutes
- Increase fluid intake (2–3 L/day unless contraindicated)
- Increase salt intake (if no HTN/HF)
- Compression stockings (waist-high)
- Elevate head of bed 10–20 degrees (reduces nocturnal diuresis)
- Avoid large meals, alcohol, hot environments
Medication review:
- Reduce/stop offending agents: diuretics, alpha-blockers, vasodilators, tricyclics, antipsychotics
- Time antihypertensives to avoid peak effect during high-risk activities
Pharmacologic (if refractory):
| Drug | Dose | Contraindications | Monitoring | Cost | Notes |
|---|---|---|---|---|---|
| Midodrine | 2.5–10 mg TID | Supine HTN; urinary retention | Supine BP | $$ | First-line pharmacotherapy; last dose by 6 PM |
| Fludrocortisone | 0.1–0.2 mg daily | HF; uncontrolled HTN | K, BP, edema | $ | Volume expansion; watch for supine HTN |
| Droxidopa | 100–600 mg TID | Severe CAD; concurrent pressor use | Supine BP | $$$$ | For neurogenic orthostatic hypotension |
| Pyridostigmine | 30–60 mg TID | Bradycardia; asthma; GI obstruction | HR; cholinergic symptoms | $$ | May help without supine HTN |
Follow-up: 2–4 weeks after medication changes; recheck orthostatic vitals. Consider autonomic specialist referral if refractory.
Managing supine hypertension (common with midodrine/fludrocortisone):
- Elevate head of bed 10–20 degrees
- Avoid supine position during day; last midodrine dose by 6 PM
- If severe (SBP >180 supine): may need to reduce pressor dose or add bedtime short-acting antihypertensive (captopril 25 mg, losartan 25 mg, or hydralazine 25 mg)
- Balance: some supine HTN is acceptable if orthostatic symptoms are controlled
When orthostatics are falsely negative:
- Patient may be volume-repleted at time of testing (just drank fluids)
- Symptoms may be postprandial (test after meals)
- Autonomic dysfunction may require prolonged standing (10+ minutes) to manifest
- Consider repeat testing or tilt table if high clinical suspicion
Cardiac syncope (arrhythmia, structural)#
Education:
- Cardiac syncope is potentially life-threatening and requires thorough evaluation
- Activity restrictions until cleared by cardiology
- May require device therapy (pacemaker, ICD) or ablation
Treatment:
Immediate:
- Cardiology referral (urgent if high-risk features)
- Activity restriction: no driving, avoid heights, avoid swimming alone
- Treat underlying condition per cardiology guidance
By etiology (cardiology-directed):
| Condition | Management |
|---|---|
| Bradycardia (sick sinus, AV block) | Pacemaker |
| VT with structural heart disease | ICD; antiarrhythmics; ablation |
| SVT with syncope | Ablation; AV nodal agents |
| Long QT syndrome | Beta-blocker; avoid QT-prolonging drugs; ICD if high risk |
| Aortic stenosis | Valve replacement |
| HCM | Beta-blocker; avoid dehydration; ICD if high risk |
Follow-up: Per cardiology. PCP role is coordination, medication management, and ensuring compliance with activity restrictions.
Situational syncope#
Education:
- Triggered by specific activities (urination, defecation, coughing, swallowing)
- Benign but can cause injury; prevention is key
- Same mechanism as vasovagal (vagal activation)
Treatment:
Non-pharmacologic:
- Sit during triggering activities (especially micturition syncope—sit to urinate)
- Avoid straining (treat constipation, suppress cough)
- Stay hydrated
- Recognize prodrome and use counterpressure maneuvers
Pharmacologic:
- Rarely needed; same agents as vasovagal if refractory
Follow-up: PRN; reassurance is usually sufficient.
Follow-up#
- Vasovagal, single episode, low risk: PRN; return if recurrent or change in pattern
- Orthostatic hypotension: 2–4 weeks after intervention to recheck vitals
- Cardiac syncope: per cardiology; PCP coordinates care
- Unexplained recurrent: ensure monitoring completed; consider implantable loop recorder referral
Driving restrictions:
- Varies by state and diagnosis
- General guidance (verify local requirements):
- Vasovagal with prodrome: typically can drive once trigger avoidance strategies in place; some states require symptom-free period (often 1–3 months)
- Vasovagal without prodrome: longer restriction (3–6 months symptom-free)
- Cardiac syncope: no driving until treated and cleared by cardiology (often 6 months for ICD, 1 week for pacemaker)
- Unexplained syncope: no driving until diagnosis established
- Commercial drivers: stricter requirements; often need cardiology clearance and longer symptom-free periods
- Document counseling in chart
Elderly patients with multifactorial syncope:
- Common scenario: orthostatic hypotension + polypharmacy + carotid sinus hypersensitivity + arrhythmia
- Address ALL contributing factors, not just the most obvious one
- Medication reconciliation is critical—often multiple culprits
- Lower threshold for cardiology referral
- Fall risk assessment and home safety evaluation
Patient instructions#
- If you feel faint (lightheaded, warm, nauseated), lie down immediately or sit and put your head between your knees.
- If you can’t lie down, cross your legs and squeeze your thighs together, or grip your hands and tense your arms—this can prevent fainting.
- Rise slowly from lying or sitting; sit at the edge of the bed before standing.
- Drink plenty of fluids (unless your doctor has restricted fluids) and don’t skip meals.
- Avoid prolonged standing, hot environments, and alcohol.
- Do not drive until your doctor says it’s safe.
- Seek immediate care if you faint during exercise, have chest pain or palpitations before fainting, or injure yourself during a faint.
Smartphrase snippets#
Syncope, vasovagal: Classic prodrome (lightheadedness, warmth, nausea) with identifiable trigger (prolonged standing). Rapid recovery, no confusion. Normal ECG, negative orthostatics. Low risk. Discussed counterpressure maneuvers, hydration, trigger avoidance, and return precautions.Syncope, orthostatic hypotension: Syncope/presyncope with position change. Orthostatic vitals positive (supine BP X, standing BP Y with symptoms). Likely medication-related [or dehydration]. Adjusted [medication]. Discussed slow position changes, hydration, and follow-up.Syncope, high risk features: [Describe features]. ECG shows [findings]. Referred to cardiology urgently. Advised no driving until cleared. Discussed return precautions.
Related pages#
- Dizziness/Vertigo — if presyncope vs vertigo unclear
- Palpitations — if arrhythmia suspected
- Orthostatic hypotension — detailed orthostasis management
- Falls (geriatric) — if fall with syncope in elderly
- Chest pain — if cardiac syncope suspected
Coding/billing notes#
- Document detailed history including prodrome, triggers, position, activity, witness account
- Document orthostatic vitals with timing and symptoms
- Document ECG interpretation
- Document risk stratification reasoning
- Document driving counseling
- If not pursuing extensive workup, document rationale (e.g., “classic vasovagal with clear trigger, normal ECG, low-risk features”)
Key references#
- 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope (Circulation 2017)
- 2018 ESC Guidelines for the Diagnosis and Management of Syncope (Eur Heart J 2018)
- Canadian Syncope Risk Score validation (CMAJ 2016)
- POST trial: beta-blockers in vasovagal syncope (Circulation 2006)